![Thomas Folinsbee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Folinsbee
Directeur/Membre du Conseil chez
CASI PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2026
Profil
Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 0 ( -.--% ) | - $ | 31/03/2026 |
Postes actifs de Thomas Folinsbee
| Sociétés | Poste | Début |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/03/2023 |
Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Thomas Folinsbee
| Sociétés | Poste | Fin |
|---|---|---|
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Directeur/Membre du Conseil | 01/01/2019 |
| 3SBIO INC. | Corporate Officer/Principal | 01/01/2019 |
Hisanaga Seisakusho Co. Ltd. | Directeur/Membre du Conseil | 01/01/2016 |
| SUMT HEAL | Directeur/Membre du Conseil | - |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | - |
Formation de Thomas Folinsbee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hisanaga Seisakusho Co. Ltd. | |
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
Summit Healthcare Acquisition Corp.
 Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Alebund Pharmaceuticals Ltd. | |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
